Vitek Tracz

Last updated

Vitek Tracz
Vitek Tracz.jpg
Vitek Tracz, London-based publishing entrepreneur.
Born (1940-05-31) 31 May 1940 (age 83) [1]
OccupationChairman of Sciencenow Group
Known forFounding Current Opinion journals, Current Biology , BioMedNet, BioMed Central, Faculty of 1000, Current Drugs, Telmap
SpouseDalia Tracz
Website blog.f1000.com/author/vitek-tracz/

Vitek Tracz (born 31 May 1940) is a London-based entrepreneur who has been involved in science publishing, pharmaceutical information and mobile phone-based navigation.

Contents

Early life

Tracz was born in 1940 in Poland. He studied mathematics in Warsaw and Jerusalem, before studying film-making at the Slade School of Fine Art. [2] He collaborated with Israeli writer Hanoch Levin on the 1978 feature film Fantasia Al Noseh Romanti.

Business career

In academic publishing, Tracz is known as the founder of the Current Opinion journals (which, along with the research journal Current Biology and the early scientific community websites BioMedNet and Chemweb, were acquired by Elsevier in 1997), and open access publisher BioMed Central (acquired by Springer Science+Business Media in 2008). [3]

In 2004, Tracz was invited to give oral evidence to the House of Commons Science & Technology Committee as part of its inquiry into scientific publishing and open access.

Tracz's group of companies, currently known as the Sciencenow Group (formerly Science Navigation Group), previously published The Scientist (a popular science magazine with all print and web content freely available online), and currently publishes Faculty of 1000 (a subscription-only current awareness service highlighting recent biological and medical research). Other companies that have been part of the group in the past include Current Medicine, a publisher medical books, journals, websites and the Images.MD medical image database (both acquired by Springer in 2005), Current Biology and the Current Opinion journals (acquired by Elsevier), and Global DataPoint. Other businesses founded by Tracz include Current Drugs (acquired by Thomson Corporation in 2002), [4] and Telmap, a mobile phone navigation company (acquired by Intel in 2012).

In recent years, Tracz's business has focused on activities under the Faculty of 1000/F1000 brand. Faculty of 1000 began as a literature evaluation service, but more recently allowed the publication of original scientific posters (F1000 Posters) and research articles (F1000 Research). [5] F1000 has generated some controversy[ citation needed ] with its use of an innovative and rapid form of peer review. [6] In January 2020, F1000 Research was acquired by Taylor & Francis Group, an Informa Company. [7] Sciencenow Group continues to offer the literature evaluation service, now branded Faculty Opinions, [8] alongside Sciwheel, a reference management solution.

Sciencenow Group is also responsible for Web of Stories, a collection of multi-hour video interviews with leading scientists and other major cultural figures, looking back at their career and work. Each video is divided into short segments which are connected together to create a "web of stories", showing differing perspectives on major themes such as the Manhattan Project.

Tracz remains chairman of Sciencenow Group, [9] which acts as an incubator for his new businesses. Tracz's businesses have been largely self-funded, without external investment. [10]

Tracz has a reputation as an innovator in a tradition-bound industry, [11] being described by Richard Smith (former editor of the BMJ) as 'the Picasso of science publishing'. [12]

Interests

Tracz is an art collector, with a focus on Expressionism. [13]

Related Research Articles

BioMed Central (BMC) is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. BioMed Central describes itself as the first and largest open access science publisher. It was founded in 2000 and has been owned by Springer, now Springer Nature, since 2008.

Richard Smith CBE FMedSci is a British medical doctor, editor, and businessman.

<span class="mw-page-title-main">Taylor & Francis</span> Commercial publishing group

Taylor & Francis Group is an international company originating in England that publishes books and academic journals. Its parts include Taylor & Francis, Routledge, F1000 Research and Dovepress. It is a division of Informa plc, a United Kingdom–based publisher and conference company.

<span class="mw-page-title-main">Wellcome Trust</span> British healthcare research charity established in 1936

The Wellcome Trust is a charitable foundation focused on health research based in London, in the United Kingdom. It was established in 1936 with legacies from the pharmaceutical magnate Henry Wellcome to fund research to improve human and animal health. The aim of the Trust is to "support science to solve the urgent health challenges facing everyone." It had a financial endowment of £29.1 billion in 2020, making it the fourth wealthiest charitable foundation in the world. In 2012, the Wellcome Trust was described by the Financial Times as the United Kingdom's largest provider of non-governmental funding for scientific research, and one of the largest providers in the world. According to their annual report, the Wellcome Trust spent GBP £1.1Bn on charitable activities across their 2019/2020 financial year. According to the OECD, the Wellcome Trust's financing for 2019 development increased by 22% to US$327 million.

F1000 is an open research publisher for scientists, scholars, and clinical researchers. F1000 offers a different research evaluation service from standard academic journals by offering peer-review after, rather than before, publishing a research article. Initially, F1000 was named after the 1,000 faculty members that performed peer-reviews, but over time F1000 expanded to more than 8,000 members. When F1000 was acquired by Taylor & Francis Group in January 2020, it kept the publishing services. F1000Prime and F1000 Workspace were acquired by different brands.

Springer Science+Business Media, commonly known as Springer, is a German multinational publishing company of books, e-books and peer-reviewed journals in science, humanities, technical and medical (STM) publishing.

<i>The Scientist</i> (magazine) Professional life science magazine

The Scientist is a professional magazine intended for life scientists. The Scientist covers recently published research papers, current research, techniques, and other columns and reports of interest to its readers.

<span class="mw-page-title-main">Wiley-Blackwell</span> Journal publishing business of John Wiley & Sons

Wiley-Blackwell is an international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons. It was formed by the merger of John Wiley & Sons Global Scientific, Technical, and Medical business with Blackwell Publishing in 2007.

<span class="mw-page-title-main">Hindawi (publisher)</span> Scientific and medical journal publisher

Hindawi is a publisher of peer-reviewed, open access, scientific journals currently active in scientific, technical, and medical (STM) literature. It was founded in 1997 in Cairo, Egypt, but purchased in 2021 by John Wiley & Sons, a publishing company based in the United States. The company has its headquarters in London, an office in Cairo, and a virtual office address in New York City.

<span class="mw-page-title-main">Robert Gerlai</span> Canadian behaviour geneticist

Robert T. Gerlai is a Canadian behaviour geneticist.

Open peer review is the various possible modifications of the traditional scholarly peer review process. The three most common modifications to which the term is applied are:

  1. Open identities: Authors and reviewers are aware of each other's identity.
  2. Open reports: Review reports are published alongside the relevant article.
  3. Open participation: The wider community are able to contribute to the review process.

Acupuncture in Medicine is a bi-monthly peer-reviewed medical journal covering aspects of acupuncture and related techniques. The journal was established in 1982 by the British Medical Acupuncture Society, but was published by the BMJ Group on behalf of the Society from 2008 to 2018 and SAGE Publishing from 2019. The current editor-in-chief is David Coggin-Carr.

Peerage of Science was a scientific peer review service aimed at improving "the current peer review system and make the peer review process more scientific, fair and transparent". The company was founded in 2011 by the scientists Janne Kotiaho, Mikko Mönkkönen, and Janne-Tuomas Seppänen in Jyväskylä, Finland. Initially it focused on the areas of "ecology, evolutionary biology and conservation biology", but within 2 years it expanded to other areas of science.

BMJ Open is a peer-reviewed open access medical journal that is dedicated to publishing medical research from all disciplines and therapeutic areas. It is published by BMJ and considers all research study types, from protocols through phase I trials to meta-analyses, including small, specialist studies, and negative studies. Publishing procedures are built around fully open peer review and continuous publication, publishing research online as soon as the article is ready. BMJ Open aims to promote transparency in the publication process by publishing reviewer reports and previous versions of manuscripts as prepublication histories. The editor-in-chief is Adrian Aldcroft.

BioMed Research International is a peer-reviewed open access scientific journal covering all aspects of biomedical sciences. It was established in 2001 as the Journal of Biomedicine and Biotechnology with Abdelali Haoudi as first editor-in-chief. The journal obtained its current title in 2013 and is published by Hindawi Publishing Corporation.

Current Opinion is a series of medical journals published by Wolters Kluwer imprint Lippincott Williams & Wilkins. Wolters Kluwer acquired the journals from the Thomson Organisation in 1997. Each of these journals publishes editorials and reviews within one of a number of medical disciplines.

Springer Nature or the Springer Nature Group is a German-British academic publishing company created by the May 2015 merger of Springer Science+Business Media and Holtzbrinck Publishing Group's Nature Publishing Group, Palgrave Macmillan, and Macmillan Education.

B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.

<span class="mw-page-title-main">History of open access</span>

The idea and practise of providing free online access to journal articles began at least a decade before the term "open access" was formally coined. Computer scientists had been self-archiving in anonymous ftp archives since the 1970s and physicists had been self-archiving in arXiv since the 1990s. The Subversive Proposal to generalize the practice was posted in 1994.

medRxiv is an Internet site distributing unpublished eprints about health sciences. It distributes complete but unpublished manuscripts in the areas of medicine, clinical research, and related health sciences without charge to the reader. Such manuscripts have yet to undergo peer review and the site notes that preliminary status and that the manuscripts should not be considered for clinical application, nor relied upon for news reporting as established information.

References

  1. Rabesandratana, Tania (4 October 2013). "The Seer of Science Publishing". Science Magazine. UK. Retrieved 12 January 2014.
  2. "Media resources". Sciencenow group. Retrieved 17 May 2021.
  3. "Springer Acquires BioMed Central Group". Springer Science+Business Media.
  4. "Thomson Reuters company history". Thomson Reuters. Retrieved 12 January 2014.
  5. Macilwaine, Colin (20 January 2011). "'Facebook of Science' Seeks to Reshape Peer Review". Chronicle of Higher Education. Retrieved 19 March 2014.
  6. Hunter, Jane (30 August 2012). "Post-publication peer review: opening up scientific conversation". Front Comput Neurosci. 6: 63. doi: 10.3389/fncom.2012.00063 . PMC   3431010 . PMID   22969719.
  7. Price, Gary (10 January 2020). "Scholarly Publishing: Taylor & Francis Acquires F1000 Research". LJ infoDOCKET. Retrieved 9 February 2021.
  8. "F1000 Prime is now called Faculty Opinions". library.med.utah.edu. Retrieved 9 February 2021.
  9. Tracz, Vitek. "About Vitek Tracz". F1000. Retrieved 12 January 2014.
  10. Poynder, Richard. "Interview with Vitek Tracz: Essential for Science". Information Today. Retrieved 12 January 2014.
  11. Rayner, Daryl. "ATG Interviews Vitek Tracz". Against The Grain. The Charleston Conference. Retrieved 19 March 2014.
  12. Smith, Richard (13 November 2012). "Accelerating towards the future of publishing science". BMJ. Retrieved 19 March 2014.
  13. Gleadell, Colin (21 December 2010). "Victorians no match for moderns". Daily Telegraph. Retrieved 12 January 2014.